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Abstract  
BACKGROUND: Thyroid carcinomas (TC) are the most common endocrine malignancies. In some parts of the 
world, the incidence of TCs has increased over the past few decades, especially in females according to some 
studies.  
AIM: We have set as the objective for our study to analyse the demographic, ultrasound features, thyroid 
hormonal status and frequency of thyroid carcinomas in the Republic of Macedonia according to histopathological 
type. 
MATERIALS AND METHODS: Retrospective analysis of medical data from all diagnosed and treated patients 
with TC at the Institute of Pathophysiology and Nuclear Medicine for the period 1999-2010 was performed. 
Demographic characteristics: age at diagnosis, gender, histopathological type of TC and from clinical features: US 
findings and thyroid hormonal state at initial examination and their distribution in eight state regions were 
evaluated. 
RESULTS: Total number of 204 patients with TC in the Republic of Macedonia was registered. Papillary thyroid 
carcinoma (PTC) was the most frequent with 131 pts (64.21%), follicular (FTC) with 13 pts (6.37%) was second 
thyroid malignoma, followed by medullary (MTC) with 12 pts (5.88%), anaplastic (ATC) 11 pts (5.39%) and the 
rarest types were Hurtle cell carcinoma and intrathyroid sarcoma with only 1 diagnosed case. Age varied widely 
from 7 yrs to 88 yrs age (average 47.9 ± 16.6 yrs). PTC was more prevalent in younger age groups, while ATC 
was diagnosed in elderly patients. In all of the eight-country regions, the prevalence rate was higher for females 
than males (3:1) or 15.21/10
5
 female to 5.03/10
5
 male prevalence rate. According to US appearance mostly TC 
was unilateral in 42.65% and multifocal in 7.84% with dimensions from 15 to 50 mm. 
CONCLUSION: There is an increase in incidence and prevalence rate of TCs in our country, mostly PTC, while 
reduction exists in the number of diagnosed cases of ATC and FTC, comparing with previous studies before 
iodine prophylaxis program. Different from described in the literature is female: male (4:1) ratio for ATC. According 
to US features, we can conclude that introduction of more detailed reporting system may improve diagnostic 
accuracy.
 
 
 
Introduction 
 
Thyroid carcinomas (TC) are the most 
common endocrine malignancies. In some parts of the 
world, the incidence of TC has increased over the 
past few decades, especially in female patients 
according to some studies [1-3].  Thyroid 
malignancies are a heterogeneous group of tumors, 
with papillary (PTC) and follicular thyroid carcinomas 
(FTC) known as follicular cell-derived or differentiated 
thyroid carcinomas, medullary thyroid carcinoma 
(MTC) originating from neuroendocrine calcitonin-
producing C – cells and less common anaplastic 
thyroid carcinoma (ATC) with poor prognostic 
outcome and very rare intrathyroid lymphomas 
originating from intrathyroid lymphoid tissue and 
sarcomas arising from intrathyroid connecting tissue 
[4-6].  
Advances in histopathology techniques, 
immunohistochemical staining and molecular 
pathology reveal that there are further subtypes in 
differentiated thyroid carcinomas, PTC and FTC, with 
different genetic alterations, different histopathological 
features and different prognosis and outcome. 
Described subtypes of PTC are: typical variant, 
follicular variant of PTC, tall cell, oncocytic, columnar 
cell, diffuse sclerosing, solid, clear cell, cribriform 
morular, macrofollicular, PTC with fasciitis-like stroma, 
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PTC with prominent hobnail features, Warthin – like 
PTC, mixed papillary and medullary thyroid carcinoma 
and PTC with dedifferentiation to ATC [6]. FTC is 
divided into subtypes according to the patterns of 
growth related to capsular and vascular invasions into 
minimally invasive follicular carcinoma (MIFC) and 
widely invasive follicular thyroid carcinoma (WIFC), 
and according to the World Health Organisation 
(WHO) Hürthle cell, adenocarcinoma is also included 
as a variant of FTC [7-9]. Poorly differentiated thyroid 
carcinoma (PDTC) as a distinct group between 
differentiated thyroid carcinoma and ATC was 
originally described in1983 and included in the WHO 
classification of thyroid tumours in 2004. 
 
A consensus conference held in Turin in 2006 
confirmed geographical differences among claimed 
forms of PDTC according to suggested diagnostic 
algorithm based on the presence of a 
solid/trabecular/insular pattern and high-grade 
features. Evaluation recognised some overlap with 
solid and tall cell variants of PTC and FTC with 
predominant solid and trabecular growth pattern [10]. 
Insular thyroid carcinoma (ITC) was firstly described in 
1984 by Carcangiu et al., as a distinct 
clinicopathological entity. ITC is characterised by 
insulae consisted of small, uniform cells sometimes 
associated with small thyroglobulin-containing 
follicules and according to its aggressive biology and 
the worst prognosis is included into the PDTC group 
of thyroid tumours [11,12]. MTC include sporadic (not 
inherited), MEN 2A and MEN 2B (multiple endocrine 
neoplasias, genetic syndromes that involve other 
parts of the endocrine system), and familial (inherited, 
but not linked to other MEN-related endocrine 
tumours). Metastatic thyroid tumours (ms) are also 
included in thyroid malignancies, mostly resulting from 
contiguous infiltration from carcinoma of the larynx, 
oesophagus or by hematogenous dissemination from 
breast, lung, kidney carcinoma, metastatic deposits 
from melanoma, etc. [13]. 
 
Due to the deficit of state cancer register and 
absence of published papers about TC in the 
population of Republic of Macedonia we have set as 
the objective for our study to analyse the 
demographic, ultrasound features and the frequency 
of thyroid carcinomas in the Republic of Macedonia 
according to histopathological type for the period 
1999-2010. 
 
 
Materials and Methods 
 
Retrospective analysis of data of all 
diagnosed and treated patients with TC at the Institute 
of Pathophysiology and Nuclear Medicine for the 
period 1999 – 2010 was performed. For the analysed 
period our Institute was the healthcare institution that 
treats most of the patients with thyroid carcinomas. 
From the total number of diagnosed patients with TC, 
their demographic characteristics were evaluated: age 
at diagnosis, gender, histopathological type of TC, 
while from the clinical features: US findings and 
thyroid hormonal state at initial examination.  
Using the basic demographic indicators from 
Statistical State Office and data from census in 1994 
and 2002 we assessed the yearly incidence rate per 
100.000 female and male, differences in incidence 
rate and prevalence rate of different histopathological 
types between gender and their distribution in age 
groups, dividing the patients into four age groups (0-
19, 20-40, 41-60 and >61 years). Regional distribution 
of histopathological types of TC in R Macedonia was 
analysed also. Incidence and prevalence rate of 
distinct types of TC were evaluated for eight 
geographical regions of the whole country according 
to data from the Republic State Statistical Office from 
2009 [14]. 
 
Initial US features were analysed, and from 
the initial  US representation were recorded 
dimensions of the thyroid nodules, echogenicity, the 
presence of calcifications, enlarged neck lymph nodes 
and localisation of a tumour. According to the 
dimensions, thyroid nodules were divided into four 
groups (occult tumours in the absence of the clearly 
defined lesion in the thyroid gland, small tumours <15 
mm, 15 – 50 mm, gross tumours > 50 mm). Multifocal 
or multicentric TCs were also described as the distinct 
group according to findings from the histopathological 
report. Another described US feature was the 
echogenicity and according to this characteristic we 
have described anechoic, hyperechoic, hypoechoic, 
isoechoic and heterogeneous nodules, also the 
presence/absence of calcifications, localisation 
(isthmic, right, left lobe and bilateral) and detection of 
enlarged neck lymph nodes at the initial 
representation of the patients. 
 
 
 
Results 
 
A total number of 204 patients with TC in R 
Macedonia was registered. The Annual incidence rate 
showed the slight increase of thyroid malignomas 
comparing with previous studies for the period 1966-
1980, with the highest incidence rate in 2000 when 
1.18/10
5
 was recorded. The evaluated prevalence rate 
for our population increased from 6.5/10
5 
in 1966-
1980 to 10.15/10
5 
in 1999-2010 [15]. Average 
disease-specific mortality for the period 1999-2010 
was 0.044/10
5 
[15]. Distribution according to the 
histopathological type of TC showed that papillary 
thyroid carcinoma (PTC), for the analysed period 
including all histopathological variants of PTC was the 
most frequent with 131 pts (64.21%). From known 
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histopathological variants of PTC in our population 
most common was typical PTC with 97 pts (47.55%) 
then second according to frequency was follicular 
variant of PTC 29 pts (14.21%), 4 cases (1.96%) PTC 
with osteoclast-like multinucleated giant cells PTC and 
PTC with nodular fasciitis-like stroma 1 case (0.49%). 
Follicular thyroid carcinoma (FTC) with 13 pts (6.37%) 
was the second thyroid malignoma according to 
frequency, followed by MTC with 12 pts (5.88%), 
anaplastic (ATC) 11 pts (5.39%) and rarest types 
were Hurtle cell variant of follicular carcinoma and 
intrathyroid sarcoma with only 1 diagnosed patient 
respectively for the evaluated period (Figure 1). 
 
Figure 1: Annual frequency of TC by histopathological type
 
 
From the demographic features, we have 
analysed age of the patients at the time of diagnosis. 
Age of the patients varies widely from 7 yrs to 88 yrs 
age (average 47.9 ± 16.6 yrs) (Figure 2a). Annual 
average age of the patients in the moment of 
diagnosis was calculated and according to this data 
youngest patients were diagnosed in 2002 with an 
average age of 36 years (± 16.18) and oldest in 2001 
with an average age of 57.9 years (± 10.87) (Figure 
2b).  
 
Figure 2: Distribution of TC by age groups. a) Frequency of all TC 
by age groups; b) Average age of the patients at the diagnosis 
yearly 
 
Analysis of the distribution of histopathological 
types by age indicates that PTC was more prevalent 
in younger age groups, while ATC was diagnosed in 
age groups above 40 years and the highest frequency 
above 61 years in elderly patients. The average age 
for PTC was 43 (± 14.7) yrs, 51.8 yrs (± 16.6) for FTC, 
47.5 (± 18.9) yrs for MTC and 67 (± 8.3) yrs for ATC 
(Figure 3).  
 
Figure 3: Distribution of different histopathological types by age 
groups 
 
Age-standardized distribution of TC in both 
genders indicates that in females TCs were most 
frequently in age groups from 20-40 years and with 
almost similar frequency in the age group 41-60, while 
in male most TCs were distributed in the age group 
41-60 and older age above 61 years (Figure 4).
 
 
Figure 4: Distribution of TC by gender according to age groups
 
 
The incidence rate of TC related to gender 
was evaluated and around three times higher 
incidence rate was recorded in female population than 
a male with the exception in 1999 when slightly higher 
incidence rate in the male population of 0.69/10
5
 
compared to a female with an incidence rate of 
0.59/10
5 
(Figure 5). Analysis revealed three times 
higher prevalence rate (15.21/10
5
)
 
of TC in female 
compared to (5.03/10
5
)
 
male gender.   
 
Figure 5: Annual incidence rate by gender/100.000 f/m (1999-2010) 
 
Distribution of histopathological types by 
gender revealed a similar pattern in female and male 
population, with PTC type as most frequent in both 
genders and MTC second most prevalent TC in 
female and FTC in the male population. Anaplastic 
thyroid carcinoma was more frequently diagnosed in 
female than male in our population (Figure 6). 
 
 
Figure 6: Distribution of different histopathological types by gender 
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The prevalence rate of TC by gender per 
100.000 female and male individuals in eight regions 
of our country were analysed.  In all regions, 
prevalence rate was higher for female population than 
male, especially in Vardar region where only female 
TC pts were diagnosed for the analysed period. The 
highest prevalence rate for male population was 
detected in East region, while for a female in Skopje 
region (Figure 7).
 
 
Figure 7: Prevalence rate by gender in eight regions of our country 
 
According to ultrasound (US) appearance of 
TC at initial presentation, 12 cases were diagnosed as 
occult thyroid carcinoma because of absence of 
clearly defined lesion in thyroid gland, 149 pts were 
with detected thyroid nodules on the US, from which 
93 pts were with one nodule, struma nodosa 
athyreotic (SNE) and 56 pts with multinodular goiter, 
struma multinodosa athyreotic (SMNE) and 43 pts 
lacking first US examination descriptions in medical 
files, mostly due to the fact that their first examination 
at our Institute was preformed after the surgical 
treatment or TC was incidentally diagnosed after 
thyroidectomy of multinodular goiter. Another 
parameter that derived from US examination and 
additional pathology report features, was the largest 
diameter of the thyroid nodule at first examination and 
thereafter at intervention and appropriately according 
to dimensions we have divided pts in to four groups, 
respectively as small thyroid tumors less than 15 mm, 
15 – 50 mm, large tumors > 50 mm and multifocal 
carcinoma. Mostly TCs were unilateral and with 
dimensions from 15 to 50 mm with 42.65% and the 
rarest were multifocal with 7.84%. According to US 
appearance, most nodules were described as 
hypoechoic (29.9%), and with similar representation 
heterogeneous (29.4%), hyperechoic solid nodules 
(5%), isoechoic (3.4 %) and rarest anechoic cystic 
lesions (1.5%), in 30.9% description of echogenicity of 
the nodule was missing. In 19% of TC presence of 
calcifications were described. Nodules were usually 
localised in thyroid lobes more frequently in the right 
lobe (34.8%), than left lobe (26.5%), rarely with 
bilateral involvement (8.3%) and lesions with thyroid 
isthmus involvement with only 4.4%. In 30% of 
patients on the initial US were detected enlarged neck 
lymph nodes. According to thyroid hormonal status at 
initial examination most of the patients were euthyroid 
153/204 (75%), subclinical hypothyroidism had 11/204 
(5.39%), subclinical hyperthyroidism had 8/204 
(3.92%), hyperthyroid state was detected in 4/204 
(1.96%) and hypothyroid only in 1/204 (0.49%) (Table 
1). 
Table 1: The US features at initial examination of diagnosed 
thyroid carcinomas 1999-2010
 
Nodules Pts (%) Echogenicity Pts (%) 
Occult 12 5.88% Anechoic 3 1.471% 
SNE 93 45.59% Hyperechoic 10 4.902% 
SMNE 56 27.45% Hypoechoic 61 29.902% 
Without data 43 21.08% Isoechoic 7 3.431% 
 
  
Heterogeneous  60 29.412% 
  
Without data 63 30.882% 
Dimensions Pts (%) Localisation pts (%) 
<15 mm 20 9.804% Isthmic 9 4.412% 
15 - 50 mm 87 42.647% Right lobe 71 34.804% 
> 50 mm 23 11.275% Left lobe 54 26.471% 
Multifocal 17 8.333% Bilateral 17 8.333% 
Without data 57 27.941% Without data 53 25.980% 
Neck lymph nodes  Pts (%) Calcifications pts (%) 
Present 55 26.961% Present 39 19.118% 
Without 125 61.275% Without  165 80.882% 
Without data 24 11.765% 
   
 
 
Discussion 
 
Thyroid carcinoma comprises a spectrum of 
different tumours with the wide range of biological 
behaviour and prognosis and from highest priority is 
the early differential diagnosis, which leads to 
appropriate treatment of the patient [16]. The 
importance of epidemiological data is in the possibility 
of giving the true distribution of the disease in the 
population and using different scientific methods, 
which indicate of possible etiological influences in the 
pathogenesis. Many studies have analysed 
epidemiological trends in TC. Gathered data showed 
that as in other countries, in our country there was a 
trend of increase in the incidence and prevalence rate, 
compared with the published data for the period 1966-
1980, from 6.5/10
5 
to 10.15/10
5
, or around 1.6 times 
increase in prevalence rate between two analysed 
decades [15, 17]. This prevalence rate is lower than 
reported in many countries and may be due to 
environmental, genetic factors or due to 
underdiagnosis of TC [3- 5].  
From all TCs in R Macedonia, PTC 
predominates with 64.21% representation, females 
affected more frequently than males in ratio 3.3:1. 
Cancer gender disparity in incidence, disease 
aggressiveness and prognosis has been observed for 
a variety of cancers, and according to literature, 
thyroid cancer has 2.9-times higher rate in women 
(data from USA study), but in the literature this gender 
disparity in TC is also specific to the histologic 
subtype, data indicates that more aggressive types of 
TC, ATC and MTC have similar rates of incidence in 
men and women. Meanwhile, differentiated thyroid 
cancer of follicular cell origin, such as FTC and PTC, 
are more common in women [18, 19]. We found same 
female/male ratio for PTC and MTC 3:1 and even 
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higher ratio for ATC of 4:1 and almost similar 
prevalence for FTC by gender. According to V. LiVolsi 
and other data from the literature, almost 80 – 85% of 
all TC are PTC, with a female: male ratio varying 2:1 
to 4:1 [3, 18, 20]. A similar distribution of 
histopathological types of TC was described in the 
Ellis Fischel Cancer Center Registry Data for the 
period 1998-2012, with registered 57% of PTC in all 
TC. Furthermore, it is concluded that this frequency of 
PTC is recorded both in iodine deficiency and iodine 
sufficiency regions and it is recognised as the most 
indolent type of TC. Evaluations of epidemiological 
trends showed that papillary microcarcinomas are 
more frequently diagnosed. One probability is that 
global increase in the incidence of TC is due to 
improved diagnosis of papillary microcarcinomas [21]. 

 
The important fact is that papillary carcinomas 
are also subdivided into different subtypes, with 
different biological behaviour. In the current study 
from 204/97 pts or 47.55% were typical PTC, then the 
second was a follicular variant with 14.21%, 1.96% tall 
cell and only 0.495 or 1 patient was PTC with nodular 
fasciitis-like stroma type [20].
 
Second most common TC is FTC with 6.37% 
representation of all TC in our population for 1999-
2010 periods. In literature, the incidence rate varies 
greatly from 10 to 32 %, the known environmental 
factor is dietary iodine intake, and it is recognised that 
greater frequency of FTC exists in iodine deficiency 
regions [22]. B. Karanfilski et al. (1990), published 
data about the distribution of TC for period 1966 – 
1988 in our country and according to those data FTC 
was represented with 17.5% in all TC. We found 2.8 
times reduction in the representation of FTC in all TC 
[17]. This observation is recorded in other studies in 
countries after the introduction of iodine deficiency 
correction programs. The territory of R Macedonia 
was iodine deficient region till 1956 when iodine 
prophylaxis program was started with the introduction 
of salt iodination with 10 mg KJ/1kg salt till 1999 when 
the second program was initiated with 20 - 30 mg 
KJO3/1 kg salt. In 2003 expert team by WHO, 
UNICEF, ICCID and National Committee conducted 
an evaluation and concluded in their final report that 
iodine deficiency in R Macedonia was corrected. 
Change in iodine intake in the analysed period is a 
possible mechanism for the lowered frequency of FTC 
in our population comparing to the study for previous 
decades [23, 24]. We assume that correction of iodine 
deficiency in R Macedonia is also the reason for the 
detected reduction in the frequency of ATC from 
17.9% (second commonest) in 1966-1988 to 5.39% in 
1999-2010. On the other hand increase in the number 
of MTC, cases were detected. This increase in MTC, 
as third most common TC with 5.88%, compared to 
2.2% in 1966-1988 published data, may be due to 
advanced diagnostic facilities. 
Age distribution of histopathological types 
showed younger age at the moment of diagnosis of 
PTC, compared to ATC in our study, described in 
other studies as well. Thyroid cancer is the only 
malignancy with age as a prognostic indicator 
included in the staging systems. The theory of the 
pathogenesis of ATC describes the possibility of 
development of this poorly differentiated TC from 
undifferentiated follicular cells of PTC with the process 
of genetic alterations leading to loss of TSH receptor 
expression and loss of iodine avidity of a tumour [25]. 
According to US features and 
histopathological data, TC was usually unilateral and 
with dimensions from 15 to 50 mm with 42.65% 
representation and most rarely was multifocal with 
7.84%. Mostly nodules were described as hypoechoic 
(29.9%) and inhomogeneous (29.4%). 30% of patients 
were detected with enlarged neck lymph nodes on the 
initial US. Many studies indicate that detection of 
nonpalpable thyroid nodules has increased with wider 
application of US and other imaging modalities [26]. 
The study revealed mostly thyroid tumours with 
dimensions from 15 to 50 mm (42.65%), while only 
9,8% were smaller than 15 mm. According to literature 
one of a possible reasons for the increase in the 
incidence of TC is improved diagnosis of 
microcarcinomas, less than 1 cm. 
 
From all patients only in 19.11% were 
described calcifications in the thyroid nodules at initial 
US examination. According to Hoang et al., one of the 
most specific US features for malignancy is the 
presence of calcifications with a described specificity 
of 85.8%–95% and positive predictive value of 
41.8%–94.2% [27, 28]. Microcalcifications represents 
psammoma bodies and are usually described in PTC, 
while coarse calcifications more likely to be found in 
MTC. This discordance between our data and 
literature may be due to the absence in the detailed 
description of US examinations according to Thyroid 
imaging reporting and data system (TIRADS) criteria 
[29]. 
 
In conclusion, there is an increase in the 
incidence and prevalence rate of TCs in R Macedonia 
for the period 1999-2010 compared with data from the 
previous study (1966-1980). According to 
histopathological type, the most common was PTC, 
second FTC, and third MTC, followed by ATC and 
most rare were Hurtle cell adenocarcinoma and 
intrathyroid sarcoma with only 1 case. Comparing with 
the data from the previous study for period 1966-1988 
in our country, there is a reduction of diagnosed ATC 
and FTC. We conclude that this change in the 
distribution of histopathological types may be due to 
the introduction of iodine prophylaxis and elimination 
of the problem of iodine deficiency in our country. All 
histopathological types were more common in females 
than males, (f/m ratio 3:1). Age-standardized 
distribution of TC in both genders indicates that in 
females TCs were more frequently diagnosed in 
younger age than in males. PTC was usually 
diagnosed in younger age (average 43 yrs), while 
ATC was mostly diagnosed in elderly people (average 
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age at diagnosis 67 yrs). Analyzed US features 
indicates that introduction of more detailed reporting 
system may improve the diagnostic accuracy. Further 
prospective studies with the introduction of TIRADS 
system on our populations are needed for evaluation 
of diagnostic accuracy of this method and selecting 
suspicious thyroid nodules for more detailed 
examinations.    
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